
Join to View Full Profile
101 The City Dr SOrange, CA 92868
Phone+1 714-456-7005
Fax+1 714-456-5342
Dr. Uchio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Minimally Invasive Urologic Surgery, 2001 - 2002
University of WashingtonResidency, Urology, 1995 - 2001
University of California, Irvine, School of MedicineClass of 1995
University of California, IrvineB.S., 1991
Certifications & Licensure
CA State Medical License 2011 - 2027
WA State Medical License 1995 - 2017
CT State Medical License 2003 - 2012
MD State Medical License 2002 - 2003
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
- Top Urologist CA The Leading Physicians of The World, 2013
- Top Urologist CT The Leading Physicians of The World, 2012
Clinical Trials
- Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma Start of enrollment: 2006 Jun 01
- Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial Start of enrollment: 2011 Jul 01
- LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve Start of enrollment: 2021 Apr 22
Roles: Contact
Publications & Presentations
PubMed
- The Establishment of Prostate-specific, SKP2 Humanized Mice by CRISPR Knock-in Method Reveals Neoplastic Initiation and Microenvironmental Reprogramming.Liankun Song, Yurong Song, Vyvyan Nguyen, Shan Xu, Kelly Ho
Research Square. 2026-01-07 - 5 citationsIrreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial.Arvin K George, Ranko Miocinovic, Amit R Patel, Derek J Lomas, Andres F Correa
European Urology. 2026-01-01 - Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary End Points.Neal D Shore, Ugo De Giorgi, Ronald F Tutrone, James L Bailen, Erik P M Roos
The Journal of Urology. 2025-12-17
Journal Articles
- Effects of androgen deprivation on cerebral morphometry in prostate cancer patients – an exploratory studyChoa HH, Hu S, Ide JS, Uchio E, Zhang S, Rose M, Concato J, Li CS, PLoS One, 8/1/2013
- Effects of androgen deprivation on brain function in prostate cancer patients - a prospective observational cohort analysisChao HH, Uchio E, Zhang S, Hu S, Bednarski SR, Luo X, Rose M, Concato J, Li CS, BMC Cancer, 8/1/2012
- Intermedin is overexpressed in hepatocellular carcinoma and regulates cell proliferation and survivalGuo X, Schmitz JC, Kenney BC, Uchio EM, Kulkarni S, Cha CH, Cancer Sci, 8/1/2012
Books/Book Chapters
Abstracts/Posters
- “Molecular Markers and Long-term Prognosis in Prostate Cancer.”Uchio EM, Jain D, Risch H, Li W, Wells CK, Concato J, Annual AUA Meeting, Chicago, IL, 1/1/2009
- “The Clinical Utility of Urine Cytology and Fluorescence in situ Hybridization (FISH) for Detecting Transitional Cell Carcinoma (TCC) in a Veterans Population.”Uchio EM, Calderon J, Neto A, Taylor J, Hwang J, Concato J, Annual AUA Meeting, Chicago, IL, 1/1/2009
- “The Role of Met Receptor Expression in Prostate Cancer.”Uchio EM, Cha C, Calderon J, Hwang J, Walker J, Sener A, Pautler, S, Annual AUA Meeting, Chicago, IL, 1/1/2009
Lectures
- “XTANDI (enzalutamide) capsules: Inhibiting the Androgen Receptor Signaling Pathway at Multiple Steps”Monterey, CA - 1/1/2013
- “New Prostate Screening Guidelines and Advances in Treatment of Prostate Cancer Utilizing Cyberknife Stereotactic Radiation”Riverside Community Hospital, Riverside, CA - 1/1/2013
- “The Evolving Role of the Urologist in Oncology"Orange, CA - 1/1/2013
Press Mentions
YOUR HEALTH: A Simpler Incision, a Targeted “Zap”, and a Faster Recovery for Prostate Cancer PatientsAugust 9th, 2019
New Ultrasound Technology Targets Prostate CancerFebruary 15th, 2019
EDAP TMS SA : UCI Health Medical Center Becomes First in the U.S. To Treat Patients Using EDAP's Breakthrough Focal One® HIFU TechnologyFebruary 5th, 2019
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









